Mortality of Patients With Inflammatory Bowel Disease in the Faroe Islands From 1966-2020
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae120 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Kári Rubek Nielsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Centre, National Hospital of the Faroe Islands, Tórshavn, Faroe Islands. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Faroese Research Council, Aage & Johanne Louis-Hansens Foundation, Faroese Foundation.
Abstract (Originalsprache)
Background
Increased mortality rates have been found in patients suffering from inflammatory bowel disease (IBD). The Faroe Islands have the highest occurrence of IBD, mainly ulcerative colitis (UC). This study investigated mortality of patients with IBD compared with the general Faroese population.
Methods
All patients diagnosed with IBD from 1966-2020 were included, as well as population mortality data. All-cause and cause-specific mortality in the IBD cohort was compared with the population by standardized incidence ratios (SIRs). Risk factors for death within the cohort were assessed by hazard ratios (HRs) using Cox regression.
Results
Overall mortality was not increased in patients with Crohn’s disease (CD; SIR 0.9; 95% confidence interval [CI], 0.56-1.35) or UC (SIR 1.0; 95% CI, 0.83-1.25). However, patients with UC had an elevated risk of dying from digestive diseases (SIR 4.3; 95% CI, 2.16-7.74). Patients with IBD had lower risk of death of cardiovascular diseases compared with the background population (SIR 0.7; 95% CI, 0.50-0.93). Risk factors for mortality included male gender, age at diagnosis, and use of steroids. Protective factors were use of 5-aminosalicylic acid (5-ASA), thiopurines, and biological treatment.
Conclusions
No increased risk of all-cause mortality in patients with CD or UC was found in this nationwide study compared with the entire Faroese population over more than 5 decades. The risk of death due to digestive diseases was, however, increased in patients with UC, while mortality risk of cardiovascular diseases was lower in patients with IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Centre, National Hospital of the Faroe Islands, Tórshavn, Faroe Islands.
- Genetic Biobank, Tórshavn, Faroe Islands.
- Department of Research, the National Hospital of the Faroe Islands, Tórshavn, Faroe Islands.
- Omicron ApS, Roskilde, Denmark.
- Gastrounit D, Medical section, Herlev and Gentofte University Hospital, Herlev, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Kári Rubek Nielsen
Förderung
- Faroese Research Council
- Aage & Johanne Louis-Hansens Foundation
- Faroese Foundation
- Torben & Alice Frimodts Foundation
- Betri Foundation
Zitieren
APA
Nielsen, K. R., Lophaven, S. N., Midjord, J., Langholz, E., Burisch, J., & Hammer, T. (2025). Mortality of Patients With Inflammatory Bowel Disease in the Faroe Islands From 1966-2020. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae120
Vancouver
Nielsen KR, Lophaven SN, Midjord J, Langholz E, Burisch J, Hammer T. Mortality of Patients With Inflammatory Bowel Disease in the Faroe Islands From 1966-2020. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae120
BibTeX
@article{Nielsen2025,
author = {Nielsen, Kári Rubek and Lophaven, Søren Nymand and Midjord, Jóngerð and Langholz, Ebbe and Burisch, Johan and Hammer, Turid},
title = {Mortality of Patients With Inflammatory Bowel Disease in the Faroe Islands From 1966-2020},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae120}
}
EUVIMED